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Biological dosimetry, based on the analysis of micronuclei
(MN) in the cytokinesis-block micronucleus (CBMN) assay
can be used as an alternative method for scoring dicentric
chromosomes in the field of radiation protection. Biological
dosimetry or Biodosimetry, is mainly performed, in
addition to physical dosimetry, with the aim of individual
dose assessment. Many studies have shown that the
number of radiation-induced MN is strongly correlated
with dose and quality of radiation. The CBMN assay has
become, in the last years, a thoroughly validated and
standardised technique to evaluate in vivo radiation
exposure of occupational, medical and accidentally ex-
posed individuals. Compared to the gold standard, the
dicentric assay, the CBMN assay has the important
advantage of allowing economical, easy and quick analysis.
The main disadvantage of the CBMN assay is related to the
variable micronucleus (MN) background frequency, by
which only in vivo exposures in excess of 0.2–0.3 Gy X-rays
can be detected.
In the last years, several improvements have been
achieved, with the ultimate goals (i) of further increasing
the sensitivity of the CBMN assay for low-dose detection by
combining the assay with a fluorescence in situ hybridi-
sation centromere staining technique, (ii) of increasing the
specificity of the test for radiation by scoring nucleoplas-
mic bridges in binucleated cells and (iii) of making the
assay optimally suitable for rapid automated analysis of
a large number of samples, viz. in case of a large-scale
radiation accident. The development of a combined
automated MN-centromere scoring procedure remains
a challenge for the future, as it will allow systematic
biomonitoring of radiation workers exposed to low-dose
radiation.
Introduction
Biological dosimetry for radiation exposure
Biological dosimetry, based on the analysis of dicentric
chromosomes, has been used since .40 years (mid 1960s)
and has become the standard test for dose assessment in the
framework of radiological protection programmes (1). In case
of a radiation accident, the first information comes especially
from physical dose reconstruction, blood count data and from
the clinical symptoms that exposed persons might display. All
these sources of information may be combined with the results
of biological dose assessments to obtain a clearer evaluation of
the case. Biological dosimetry using cytogenetic methods is of
particular importance because it takes into account inter-
individual variation in susceptibility to radiation damage.
Numerous studies, performed both on animals and humans,
have demonstrated a close relationship between dicentric
chromosomes induced in peripheral blood lymphocytes (PBLs)
under in vitro and in vivo conditions. This allows dose
estimation of an accidentally exposed person by comparing the
observed aberration yield of dicentrics to an in vitro calibration
curve. The power of dicentrics for dose estimation is related to
the low and constant spontaneous dicentric rate in the healthy
population (about one dicentric per 1000 metaphases), and by
the fact that dicentrics are specifically induced by ionising
radiation (2). After whole-body exposure with low linear
energy transfer (LET) radiation, doses down to 0.1 Gy can be
detected. However, in cases of exposure to low doses of
radiation, a disadvantage of the dicentric assay is the time
needed for microscopic scoring analysis of a sufficient number
of metaphases.
For many years, the dicentric assay performed in PBL was
the only method available; and still today, it is the gold
standard for cytogenetic radiation dosimetry. However, in the
past years, a number of additional assays (3) have been worked
out and validated, including the now well-established micro-
nucleus (MN), translocation and premature chromosome
condensation assays. More recently, molecular biomarker
methods such as the gamma-H2AX assay have been proposed
(4).
The range of biodosimetry options now available have led to
proposals for a multi-parametric approach to investigate
overexposed subjects (5).
The MN assay as biological dosimeter
The cytokinesis-block micronucleus (CBMN) assay has been
developed by Fenech and Morley in 1985 (6). MN are small
extranuclear bodies resulting from chromosome breaks or
whole chromosomes lagging behind during anaphase. They are
scored in PBL in the first interphase after cell division. These
cells can be identified as binucleated (BN) cells by addition of
the cytoplasmic division inhibitor cytochalasin B during cell
culture.
As MN can arise from exposure to various clastogenic
agents in the form of acentric chromosome fragments, as well
as to aneugenic agents as whole chromosomes, they are not
radiation specific. As a consequence, the CBMN assay is often
used as a general toxicology test (7). However, because
ionising radiation is a strong clastogenic agent, and thus
a potent inducer of MN, the CBMN assay has proven to be
a very reliable, thoroughly validated and standardised
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technique in the field of radiation biology (i) to evaluate in vivo
radiation exposure of occupational, medical and accidentally
exposed individuals and (ii) to assess individual in vitro
radiosensitivity or cancer susceptibility (8–23). Radiation-
induced chromosome aberrations such as MN observed in PBL
are mainly the result of unrepaired or misrepaired double-
strand breaks by the non-homologous end joining (NHEJ)
repair pathway (22,24).
MN dose response
Many studies showed that the number of radiation-induced MN
is strongly correlated with radiation dose and depends on the
radiation quality (25–29). For low LET radiation, linear-
quadratic dose–response functions of the form y 5 c þ aD þ
bD2 are reported, while a linear dependence (y 5 c þ aD) is
observed for high LET radiation, with the latter being more
effective in generating MN at the same dose levels. In the
equations, y represents the yield of MN/BN cells, c the
background frequency, D the absorbed dose and the a and b
coefficients refer to MN per BN cell per Gy and per Gy2,
respectively. These curve fittings follow the same shape as
described for the standard dicentric assay. However, due to
inter-laboratory differences in MN dose response caused by the
use of different protocols, scoring criteria, etc., any laboratory
intending to perform biological dosimetry, should determine
and periodically re-establish its own in vitro dose–response
calibration curves (10). Ideally, about eight dose points should
be used in the range up to 5 Gy. For doses higher than 5 Gy,
the response levels off. This phenomenon is well known also
for other cytogenetic end points such as dicentrics and is
interpreted as selection against heavily damaged cells that
cannot enter mitosis. In Figure 1, a typical example of a MN
dose–response curve for low LET radiation (60Co c-rays, dose
rate 0.5 Gy/min), based on the average MN yields per 1000 BN
cells of 10 donors (13), is shown.
Recently, a number of specialised curve-fitting computer
programs for cytogenetic end points such as dicentrics,
translocations and MN have been developed (30), like the
‘chromosomal aberration calculation software’ (CABAS) and
the ‘Dose Estimate’ tools. CABAS was developed by Deperas
et al. (31) and uses maximum likelihood methods to fit
calibration data to the linear quadratic equation. Dose Estimate
is a similar tool, which was developed at the UK Health
Protection Agency (32), allowing both linear quadratic and
linear fitting. Both CABAS and Dose Estimate include
additional tools that assist with processing data from radiation
accident cases in order to derive dose estimates when the
circumstances of the overexposure are deviating from acute or
whole-body exposure.
MN background frequencies
A drawback of the CBMN assay compared to the dicentric
assay, for applications in the low-dose range, is the inter-
individual variability of the spontaneous MN frequency (33).
Values ranging from 2 to 36 per 1000 BN cells have been
recorded (34). Due to this variable background, the CBMN
assay in its basic form could only detect in vivo exposures in
excess of 0.2–0.3 Gy X- or c-rays (10,29,35).
The two most important factors influencing the MN
background levels, besides diet (36) and exposure to en-
vironmental mutagens, are age and gender (37,38). Large-scale
biomonitoring studies have shown that the spontaneous MN
yield increases systematically with age. Values between 0.24
and 0.44 MN/1000 BN cells/year were obtained on healthy
male populations in the frame of studies performed by the
Ghent group on nuclear power plant and hospital workers
(9,11,12). Also in the large-scale Fenech study (39), in-
vestigating variables influencing baseline MN frequencies, an
increase of 0.31 MN/1000 BN cells/year was measured in
a male population. In females, the spontaneous MN yields are
Fig. 1. Linear-quadratic MN dose response for low LET 60Co c-rays. The average MN yields per 1000 BN cells of 10 donors, together with the curve fittings
through these points, are shown (full line). The fitted curves for the 95% upper confidence limit and the 95% lower confidence limit are shown as dashed lines.
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higher compared to males and the increase of MN with age is
more prominent: an increase of 0.58 MN/1000 BN cells/year
was observed by the Ghent group (12), this in good agreement
with the increase of 0.52 MN/1000 BN cells/year reported by
Fenech (39).
Investigation of the MN content using a pan-centromeric
fluorescence in situ hybridisation (FISH) probe showed that the
age increase of baseline MN frequencies can be attributed
almost completely to centromere-positive MN, reflecting
an increased chromosome loss with age (10–12). By using an
X-chromosome-specific centromeric probe, it was shown
that the X-chromosome is almost always involved in this
spontaneously occurring chromosome loss (40,41). This
finding may explain also the gender difference observed in
spontaneous MN frequencies. In the MN study mentioned
above performed on hospital workers using a pan-centromeric
probe, a mean spontaneous total MN yield of 16.4 was
obtained for males (mean age 5 41.4 years) while for females
(mean age 5 41.8 years), an MN yield of 23.5 was found. The
number of centromere-negative MN detected in this study was
not significantly different between males (6.7) and females
(7.7) (12).
Applications of the CBMN assay for biological dosimetry
To assess the suitability of the CBMN assay for biological
dosimetry, MN yields have been analysed in PBLs of different
groups of patients treated with fractionated partial body
radiotherapy, for e.g. cervical cancer, prostate cancer or
Hodgkin’s disease. The doses estimated by MN analysis agree
quite well with averaged whole body doses calculated from the
radiation treatment plans (8,42–45). Studies performed in
thyroid cancer patients undergoing radioiodine treatment
further demonstrated that the CBMN assay is sensitive enough
to detect low average whole-body doses from internal exposure
scenarios (16,23,46).
As the above-mentioned patient studies have shown that the
CBMN assay is a reliable biomarker for radiation exposure, the
CBMN assay has been used frequently to measure radiation
exposure in radiation accidents and has been applied for large-
scale biomonitoring.
In specific radiation accident studies, the CBMN assay was
applied to assess protracted exposure, due to the incorporation
of long-lived radionuclides by residents in the vicinity of the
Chernobyl nuclear power plant (47) and of the Semipalatinsk
nuclear test site (19). MN frequencies measured in a large
number of residents were significantly associated with the
estimated internal absorbed dose.
In case of small accidents involving only few patients, the
dicentric assay has generally been used to assess radiation
damage soon after the accident, and only a limited number of
studies on MN-based dosimetry are available. In the study
describing the Istanbul accident where 10 scrap metal workers
were irradiated by an unshielded former radiotherapy 60Co
source (48,49) and in the study reporting the accident of
a hospital worker exposed to a 50-kV contact radiotherapy
X-ray device during maintenance (50), several cytogenetic
end points were scored. In both radiation accidents,
blood was sampled at different time points, varying between
1 month (48,49) and 6 months (50), after the accident took
place. In both studies, MN-derived dose estimates were in
striking agreement with dose values obtained from dicentric
studies.
Large-scale biomonitoring studies on radiation workers, like
nuclear power plant workers and hospital staff, showed that the
CBMN assay, and especially the CBMN assay combined with
FISH staining for centromeres can detect radiation-induced
chromosomal damage at the population level for accumulated
doses received occupationally exceeding 50 mSv (9–13,15,17).
These biomonitoring studies, examining fairly large popula-
tions (ranging between 70 and 270 subjects) of radiation
workers occupationally exposed to accumulated doses ranging
from 10 to 248 mSv, showed a clear dependence of MN
formation on the accumulated dose. In the study performed by
the Ghent group on nuclear power plant workers (9), a linear
regression of age-corrected individual MN frequencies showed
an increase of 0.0175 MN/1000 BN cells/mSv. Application of
the CBMN centromere assay in a second study performed by
our group on nuclear power plant workers (11) resulted in
a comparable dose-dependent increase of MN, i.e. 0.025 MN/
1000 BN cells/mSv. This second study further demonstrated
that dose-dependence is completely due to centromere-negative
MN, thus pointing to the clastogenic effect of ionising
radiation. In the biomonitoring study of Vaglenov et al. (51),
an increase of 0.03 MN/1000 BN cells/mSv was also found in
nuclear power plant workers.
Significant achievements
The many applications of the CBMN assay in biodosimetry, of
which some have been described above, highlight the
important role of this cytogenetic test in assessing radiation
exposure but also its shortcomings. By tackling as well its
strong and weak points, important improvements have been
achieved during the last years. The ultimate goals of these
improvements are (i) to further increase the sensitivity of the
CBMN assay in the low-dose range, (ii) to make the assay
more specific for radiation by scoring nucleoplasmic bridges
(NPBs) in BN cells and (iii) to adapt the assay for rapid
analysis of a large number of samples.
Development of a CBMN centromere assay
As it has been shown that most of the radiation-induced MN
originate primarily from acentric fragments while spontaneous
MN contain especially whole chromosomes (10,52–55), the
application of the CBMN centromere assay, which uses a pan-
centromeric probe to discriminate between centromere-positive
and -negative MN (Figure 2a and b), substantially increases the
sensitivity of the CBMN assay in the low-dose range (10,52).
In the two studies performed by the Ghent group (10,52), it was
demonstrated that the majority of spontaneous MN were
centromere positive (73 and 71%, respectively) while most
radiation-induced MN were centromere negative. The number
of centromere-positive MN only showed a very small increase
with dose (5.3 and 3.7 MN/Gy/1000 BN cells, respectively).
By manual scoring of centromere-negative MN in 2000 BN
cells, a detection limit, at the 95% confidence limit, of 0.1 Gy
was achieved. According to the results of Pala et al. (55), this
detection limit could be even lowered to 0.05 Gy.
Scoring of NPBs in cytokinesis-blocked BN cells as
a biomarker of dicentric chromosome formation
In the cytokinesis-block micronucleus cytome (CBMN cyt)
assay (56), it is possible to score NPBs joining the two nuclei
in a BN cell. NPBs originate from dicentric chromosomes
(Figure 3), which are induced by misrepair of chromosome
The MN assay for radiation biodosimetry
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breaks. Scoring NPBs in the CBMN cyt assay for radiation
biodosimetry is important because (i) the NPB index has
a lower background frequency than MN frequency; (ii) unlike
MN background yields, the NPB frequency is not affected by
gender; (iii) NPBs in BN cells provide a direct method of
measuring asymmetrical chromosome rearrangement in cells
after a single-cell division and (iv) NPBs can be scored
efficiently because the CBMN cyt assay allows a large
proportion of BN cells to be accumulated and (v) furthermore,
MN/NPB ratio may provide a fingerprint of specific genotoxic
exposure. NPBs in lymphocytes are increased in a dose-related
manner following exposure to ionising radiation and correlate
well with dicentric and ring chromosome frequencies in
metaphases of the same lymphocyte cultures (Figure 4a and
b; 57).
Automation of the CBMN assay
Compared to the labour-intensive dicentric assay, the easy and
rapid scoring of MN makes this method very attractive for
population triage in case of large-scale radiation accidents, as
well as for large-scale assessment of genetic damage in
radiation workers receiving a high radiation dose. Algorithms
for automated MN image analysis were already developed in
the 1990s (58,59). These systems, however, showed a high
inaccuracy in classification of BN cells. More recently,
improved image analysis systems for automated MN scoring
have been developed. The MN software module integrated in
the metaphase finder system MSearch of Metasystems
(MetaSystems Hard & Software GmbH, Altlussheim, Ger-
many) automatically identifies BN cells by the occurrence of
two adjacent similarly 4#-6-diamidino-2-phenylindole-stained
nuclei. In a second step, MN are scored automatically in
a circular region defined around the two nuclei of the BN cell
(60,61). A further evaluation of the detected yield of MN by
a manual scorer is not needed. As the recognition of a BN cell
is based on the occurrence of two adjacent but unattached
nuclei, this MN software module does not allow to detect
NPBs. The system described by Decordier et al. (62) uses
a PathFinder Cellscan capture station and two MN analysis
workstations. This system, which has been developed for use in
biomonitoring of in vivo exposure to mutagenic agents,
identifies firstly the cytoplasm of Giemsa-stained cells, and
subsequently detects the number of nuclei in the cell, allowing
the identification of BN cells. MN are then scored in a third
final step.
A collaborative study performed by the Ghent group using
the Metasystems software (29) demonstrates the suitability and
advantage of automated MN scoring for population triage in
Fig. 2. (a and b) BN lymphocytes with a centromere-negative MN (a) and
a centromere-positive MN (b). The centromeres are stained with a FISH pan-
centromeric probe (spectrum orange) and the nuclei and micronuclei are
counterstained with DAPI.
Fig. 3. Formation of NPBs from dicentric chromosomes. Top panel,
centromeres of dicentric chromatids travel to the same pole of the cell and no
NPB are formed. Middle panel, centromeres of one of the dicentric chromatids
are pulled to opposite poles of the cell leading to the formation of one NPB.
Bottom panel, centromeres of both dicentric chromatids are pulled to opposite
poles of the cell leading to the formation of two NPBs. In each of the above
cases, one MN is produced from the lagging acentric chromosome fragment
accompanying the dicentric chromosome.
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case of large-scale radiation accidents, where it is important to
distinguish and isolate severely exposed individuals (1 Gy),
who require early medical follow-up and treatment.
The fully automated MN scores obtained in our study were
highly correlated with manual MN scores and demonstrated
that a visual validation step was not needed for this application
(29). The reference dose–response curve obtained for auto-
mated MN scoring, based on MN data of 10 individuals,
showed that a dose of 1 Gy can be detected with an accuracy of
0.2 Gy (Figure 5). The 95% confidence intervals of the 0 Gy
and 1 Gy doses do not overlap. Accurate dose estimations were
also achieved at the higher doses of 2 and 3 Gy. Therefore, the
automated MN scoring system validated in this study is able to
distinguish exposures with doses of 1, 2 or 3 Gy, at very
high speed: on one slide, 2000 BN cells can be scored for MN
in ,8 min.
Limitations of the CBMN assay
The major limitations of the CBMN assay are related to
retrospective dosimetry and accidents involving partial body
irradiation.
In the studies already described in Applications of the
CBMN Assay for Biological Dosimetry (48–50), where blood
samples were taken 1–6 months after the accident took place,
MN and dicentric data were also compared with data obtained
from FISH translocation tests, which are the end point of
choice for retrospective dosimetry. In the Istanbul accident, the
dose estimates obtained by MN and dicentric scoring were in
good agreement with each other, while the dose estimates
obtained by scoring translocations were 20–30% higher. In
the study reporting the accident of a hospital worker exposed to
a 50-kV contact radiotherapy X-ray device (50), a blood
sample was taken 1 year after the first sample was taken and on
this sample MN, translocations and dicentrics were scored. The
results obtained here showed that MN dissappear with a half-
life of 342 days, very close to the value of 377 days, obtained
for dicentrics. This is in agreement with the decline in MN
frequency with post-irradiation time down to 60% after 1-
year post-treatment, observed in radiotherapy patients (45).
Correction of the MN values for the delayed blood sampling in
the hospital worker resulted in a dose estimate that was in good
agreement with the estimated dose resulting from retrospective
dosimetry performed using FISH translocations in the same
study (50).
The tendency to underestimate radiation doses in situations
of delayed blood sampling is due to the fact that MN and
dicentrics represent unstable chromosome aberrations, which
have a limited in vivo persistence, especially after high doses.
Therefore, these diagnostic systems are less suitable for old or
long-term exposures (retrospective biodosimetry), whereas
FISH analysis for stable translocations remains at present the
method of choice.
A second limitation of the CBMN assay, which applies also
for the dicentric assay, is related to the fact that in practice most
accidents involve partial body exposures, whereby undamaged
PBL present outside the irradiation field will dilute the
aberration yield, leading to an underestimation of the dose of
the exposed tissue. In these cases, the dicentric assay, however,
allows an estimation of the unexposed part of the body by
comparing the distribution of aberrations among the cells with
respect to the Poisson distribution. This calculation is only
useful when a significant part of the body has received little or
no dose, when the exposed body parts received a relatively
high dose (.3 Gy) and when the exposure has taken place over
a very short period of time (63). As the distribution of MN is
slightly overdispersed (25,64), the power of an MN frequency
distribution analysis with respect to a partial body irradiation is
questionable and still needs further investigation.
Recommendations for future research
Important issues on which future research on the MN
cytogenetic assay should focus include the following.
Fig. 4. (a and b): Comparison of c-ray dose response in lymphocytes for
nucleoplasmic bridges in BN cells and dicentric chromosomes in metaphases.
In Figure 4a, the full bars represent NPB at 72 h, the squared bars represent
dicentrics at 48 h and the white bars give the yield of dicentrics at 72 h [from
Thomas et al. (57)].
Fig. 5. The fitted dose–response curve of the average MN yields per 1000 BN
cells obtained by automated MN scoring (in black), with the 95% confidence
interval (CI). The 95% CIs are based on the raw data of 10 donors. Fitted
curves for the 95% lower confidence limit (95% LCL) and the 95% upper
confidence limit (95% UCL) were added to guide the eye (grey, dashed lines).
The black arrow demonstrates a dose estimation of 1  0.2 Gy, based on the
fitted curves for average MN yields and the 95% CI [from Willems et al. (29)].
The MN assay for radiation biodosimetry
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dThe development of a combined automated MN-centromere
scoring procedure remains a challenge for the future, as it will
allow systematic biomonitoring of radiation workers exposed to
low doses. Furthermore, this implementation will allow, in the
case of mass radiation casualities, a more accurate assessment of
the exposure in a second phase—after early triage—when the
time constraint will be less strict. It will combine high-speed MN
analysis with a more accurate assessment in the low-dose range.
d The establishment of an international network including
several cytogenetic reference laboratories establishing and
optimising International Standardisation organisation (ISO)
standards for the conventional and automated CBMN assay. By
the creation of such a network of trained laboratories using
similar equipment for MN automation and the same classifiers,
standardised fixation protocols, etc., comparable results can be
obtained and the throughput of automated MN scoring can be
increased to allow a rapid response to large-scale radiation
accidents. A European programme has been started whereby
multi-disciplinary biodosimetry tools, including the CBMN
assay, will be developed in 15 European groups, to manage
high-scale radiological casualties and to increase European
capabilities in radiological incident response.
d Further refinement of the CBMN assay is needed to
optimise its use in retrospective biodosimetry and for the
analysis of cases of protracted exposure and partial body
exposure. To date, only limited and diverse data are available
concerning the disappearance of MN, and further research and
validation is needed. Appropriate calibration curves need also
to be established for more complex exposure scenarios.
Conclusions
The conventional CBMN assay is a thoroughly validated and
standardised technique for biological dosimetry. New
approaches such as centromere staining, NPB scoring and
automation of MN scoring, which have been recently
optimised, and are still under development will render the
CBMN assay more sensitive and specific for radiation dose
estimations and make it of special interest for large-scale
screening applications.
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